Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial

Jean Bourhis, Christian Sire, P. Gräff, +25

The Lancet Oncology

Advanced HeadRadiation TherapyMedicineGortec 99-02Head And Neck Cancer +6

International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma

Anne W.M. Lee, Wai Tong Ng, Jianji Pan, +23

Radiotherapy and Oncology

Tumor BiologyMedicineCancer ManagementNasopharyngeal CancerInternational Guideline +9

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra, +185

The Lancet Oncology

Concurrent ChemoradiotherapyNeoadjuvant TherapySquamous Cell CarcinomaMedicineHead And Neck Cancer +4

A randomized trial of induction docetaxel–cisplatin–5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02)

M. Frikha, A. Aupérin, Yungan Tao, +14

Annals of Oncology

MedicineMetronomic TherapyPathologyNasopharyngeal CarcinomaRandomized Trial +6

Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial

Yungan Tao, J. Biau, X.S. Sun, +22

Annals of Oncology

Ii TrialRadiation MedicineRadiation TherapySquamous Cell CarcinomaMedicine +8

Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial

Lionnel Geoffrois, Laurent Martin, D. De Raucourt, +29

Journal of Clinical Oncology

Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study

Xu-Shan Sun, Yungan Tao, Christophe Le Tourneau, +30

The Lancet Oncology

Radiation TherapyMedicineHigh-dose Cisplatin ChemoradiotherapyHead And Neck CancerDebio 1143 +7

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis

Claire Petit, Benjamin Lacas, Jean‐Pierre Pignon, +165

The Lancet Oncology

Adaptive RadiotherapyAdvanced HeadNeck CancerMedicineHead And Neck Cancer +4

Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status

Dan Ou, Pierre Blanchard, Silvia Rosellini, +14

Oral Oncology

Adaptive RadiotherapyAdvanced HeadRadiomics SignatureRadiation TherapyMedicine +8

Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.

Lucy E. Hann, Catherine S. Giess, A M Bach, +3

American Journal of Roentgenology